Medidoot Pharma (India) Private Limited
Founded in 2020 and headquartered in Uttar Pradesh, India.
2020 | Lucknow, Uttar Pradesh (India) | Active
Medidoot Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 50.00 K
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
About Medidoot Pharma (India)
Medidoot Pharma (India) Private Limited (MPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 November 2020 (Four years and three months 23 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Nitin Patel, Sachin Patel, and Vipin Patel serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909UP2020PTC137487
- Company No.
137487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Trading
Other Industry
Who are the key members and board of directors at Medidoot Pharma (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Patel  | Director | 04-Nov-2020 | Current |
| Sachin Patel | Director | 04-Nov-2020 | Current |
| Vipin Patel | Director | 04-Nov-2020 | Current |
Financial Performance of Medidoot Pharma (India).
Enhance accessibility to Medidoot Pharma (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medidoot Pharma (India)?
Unlock access to Medidoot Pharma (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Vijayarcane Indian Private Limited
Sachin Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medidoot Pharma (India)?
Medidoot Pharma (India) has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medidoot Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medidoot Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.